Antihelminthic therapy and antimony in cutaneous leishmaniasis: A randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and leishmania braziliensis

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 4, 2011, Pages 551-555

  Newlove, Tracey ^a   Guimarães, Luiz H ^b   Morgan, Daniel J ^c   Alcântara, Leda ^b   Glesby, Marshall J ^d   Carvalho, Edgar M ^b   Machado, Paulo R ^b  

^a NEW YORK UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; FERRITIN; HEMOGLOBIN; IRON; IVERMECTIN; MEGLUMINE ANTIMONATE; PLACEBO; PRAZIQUANTEL; TRANSFERRIN; ANTHELMINTIC AGENT; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; ASCARIASIS; ASCARIS LUMBRICOIDES; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; EARLY INTERVENTION; FECES ANALYSIS; FEMALE; FEVER; HEADACHE; HUMAN; INTESTINE PARASITE; IRON BLOOD LEVEL; LEG PAIN; LEISHMANIA BRAZILIENSIS; MALE; MIXED INFECTION; MYALGIA; NONHUMAN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SKIN LEISHMANIASIS; SKIN TEST; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TREATMENT DURATION; TRICHURIASIS; TRICHURIS; WEAKNESS; WOUND HEALING IMPAIRMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; HELMINTHIASIS;

LEISHMANIA BRAZILIENSIS; VERMES;

ADOLESCENT; ADULT; ANTHELMINTICS; ANTIPROTOZOAL AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HELMINTHIASIS; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; YOUNG ADULT;

EID: 79958015333     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0423     Document Type: Article

References (19)

1. Jones T, Johnson W, Barretto A, Lago E, Marsden P, 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis. J Infect Dis 156: 73-83. (Pubitemid 17089387)
2. Correia D, Macêdo V, Carvalho E, Barral A, Magalhães A, Abreu M, Orge M, Marsden P, 1996. Comparative study of meglumine antimonate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Vianna) braziliensis. Revista da Sociedade Brasiliera de Medicina Tropical 29: 447-453. (Pubitemid 26300355)
3. Romero G, Guerra M, Paes M, Macedo V, 2001. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. Am J Trop Med Hyg 65: 456-465. (Pubitemid 33134577)
4. Bacellar O, Lessa H, Schriefer A, Machado P, Jesus A, Dutra WO, Gollob KJ, Carvalho EM, 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70: 6734-6740. (Pubitemid 35387904)
5. Ribeiro-de-Jesus A, Almeida R, Lessa H, Bacellar O, Carvalho E, 1998. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 31: 143-148. (Pubitemid 128524624)
6. Bittencourt A, Barral A, 1991. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz 86: 51-56.
7. Machado P, Araújo C, daSilva A, Almeida RP, D'Oliveira A Jr, Bittencourt A, Carvalho EM, 2002. Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis 34: e69-e73.
8. DaCruz A, Oliveira MD, Luca PD, Mendonca S, Coutinho S, 1996. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 91: 225-229. (Pubitemid 126464626)
9. Almeida R, D'Oliveira A Jr, Machado P, Bacellar O, Ko AI, de Jesus A, Mobashery N, Brito Santos J, Carvalho EM, 1999. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous leishmaniasis. J Infect Dis 180: 1735-1737. (Pubitemid 29506486)
10. Lessa H, Machado P, Lima F, Cruz A, Bacellar O, Guerreiro J, Carvalho EM, 2001. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 65: 87-89. (Pubitemid 32746963)
11. Medeiros JM, Figueiredo JP, Almeida MC, Matos MA, Araújo MI, Cruz AA, Atta AM, Rego MA, de Jesus AR, Taketomi EA, Carvalho EM, 2003. Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 111: 947-951. (Pubitemid 36570852)
12. Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV, 2003. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 98: 2034-2041. (Pubitemid 37185802)
13. Maizels RM, 2005. Infections and allergy-helminths, hygiene and host immune regulation. Curr Opin Immunol 17: 656-661. (Pubitemid 41506912)
14. Araujo M, Hoppe B, Medeiros M Jr, Alcântara L, Almeida MC, Schriefer A, Oliveira R, Kruschewsky R, Figueiredo J, Cruz A, Carvalho E, 2004. Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis 190: 1797-1803. (Pubitemid 39487825)
15. O'Neal SE, Guimarães LH, Machado PR, Alcântara L, Morgan DJ, Passos S, Glesby MJ, Carvalho EM, 2007. Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J Infect Dis 195: 142-148. (Pubitemid 44958236)
16. Schriefer A, Goes-Neto A, Guimaraes LH, Carvalho LP, Almeida RP, Machado PR, Lessa HA, de Jesus AR, Riley LW, Carvalho EM, 2004. Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis. Infect Immun 72: 508-514.
17. Reed S, Badaró R, Masur H, Carvalho E, Lorenco R, Lisboa A, Teixeira R, Johnson W Jr, Jones T, 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 35: 79-85. (Pubitemid 16140841)
18. NIAID Division of AIDS Toxicity Grading Scale. Guidance, Compliance & Regulatory Information (Biologics). Available at: http://www.fda.gov/cber/ guidelines.htm. Accessed September 14, 2007.
19. Rocha H, Kirk J, Hearey C Jr, 1971. Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch Intern Med 128: 254-257.